Welcome to ICON Development Solutions, a Premier Phase 1 Research Company

ICON Development Solutions is conducting a research study of an investigational product in male/female volunteers with Type 2 Diabetes, ages 30-75.

This study may help determine the safety and tolerability of repeated oral doses of research drug with Type 2 Diabetics treated with Metformin.

Vital signs, ECG’s, physical examinations and blood and urine samples will be obtained and performed during this study.

You will need to complete:

You may be compensated up to $2,900.00 for time and travel.

Call our recruitment line for more details.

For more information on this study contact our recruitment hotline at 210-CALL-HCD (210-225- 5423)